CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 28, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other disease areas, today announced the appointment of Dr. Lloyd Klickstein as Scientific Advisor for Immunology.
kAmsC] z=:4<DE6:? 3C:?8D >@C6 E92? EH@ 564256D @7 =6256CD9:A 6IA6C:6?46 DA2??:?8 3:@A92C>246FE:42= :??@G2E:@?[ EC2?D=2E:@?2= C6D62C49[ 2?5 4=:?:42= >65:4:?6] w6 :D 2 8=@32==J C64@8?:K65 C96F>2E@=@8:DE 2?5 :>>F?@=@8:DE 2?5 4FCC6?E=J D6CG6D 2D r9:67 tI64FE:G6 ~77:46C @7 z@D=2AA %96C2A6FE:4D] w6 4@\7@F?565 '6CD2?:D q:@[ H96C6 96 96=5 >F=E:A=6 6I64FE:G6 =6256CD9:A A@D:E:@?D 367@C6 E96 4@>A2?J H2D 24BF:C65 3J t=: {:==J 2?5 r@>A2?J] q67@C6 E92E[ 96 D6CG65 2D r9:67 x??@G2E:@? ~77:46C 2E p5:46E q:@ 2?5 r9:67 $4:6?E:7:4 ~77:46C @7 C6D%~#3:@ Wp5:46EVD AC65646DD@C 4@>A2?JX[ 2?5 H2D 2? :?56A6?56?E 3@2C5 >6>36C @7 q=256 %96C2A6FE:4D] !C:@C E@ E92E[ 96 DA6?E >@C6 E92? 2 564256 2E }@G2CE:D[ H96C6 96 =65 E96 }6H x?5:42E:@?D s:D4@G6CJ &?:E H:E9:? E96 }@G2CE:D x?DE:EFE6D 7@C q:@|65:42= #6D62C49[ 7@4FD65 @? :56?E:7J:?8 2?5 6G2=F2E:?8 ?@G6= E96C2A6FE:4 E2C86ED] q67@C6 EC2?D:E:@?:?8 E@ :?5FDECJ[ sC] z=:4<DE6:? H2D 2 A9JD:4:2?\D4:6?E:DE 2E w2CG2C5 |65:42= $49@@=VD qC:892> 2?5 (@>6?VD w@DA:E2=[ H96C6 96 =65 2? }xw\7F?565 32D:4 D4:6?46 =23@C2E@CJ H9:=6 >2:?E2:?:?8 2 4=:?:42= AC24E:46]k^Am
kAmQ(6 2C6 56=:89E65 E@ H6=4@>6 sC] {=@J5 z=:4<DE6:? 2D @FC $4:6?E:7:4 p5G:D@C 7@C x>>F?@=@8J[Q D2:5 sC] y:?8D@?8 (2?8[ u@F?56C[ r92:C>2? 2?5 r9:67 tI64FE:G6 ~77:46C @7 w2C3@FC q:@|65] Q{=@J5 3C:?8D 2 F?:BF6 4@>3:?2E:@? @7 566A 4=:?:42= 6IA6CE:D6 :? C96F>2E@=@8J 2?5 :>>F?@=@8J[ 2 5:DE:?8F:D965 EC24< C64@C5 :? EC2?D=2E:@?2= D4:6?46[ 2?5 6IE6?D:G6 6IA6C:6?46 :? 25G2?4:?8 :??@G2E:G6 E96C2A6FE:4D 7C@> 5:D4@G6CJ E9C@F89 4=:?:42= 56G6=@A>6?E] w:D =6256CD9:A :? :56?E:7J:?8 2?5 G2=:52E:?8 ?@G6= E96C2A6FE:4 E2C86ED[ A2CE:4F=2C=J 5FC:?8 9:D E6?FC6 2E }@G2CE:D[ H:== 36 9:89=J G2=F23=6 2D H6 4@?E:?F6 E@ DEC6?8E96? 2?5 6IA2?5 @FC :>>F?@=@8J A:A6=:?6] (6 =@@< 7@CH2C5 E@ H@C<:?8 4=@D6=J H:E9 {=@J5 E@ 2446=6C2E6 E96 56G6=@A>6?E @7 ?6IE\86?6C2E:@? 2?E:3@5J E96C2A:6D 2?5 56=:G6C >62?:?87F= :??@G2E:@?D 7@C A2E:6?ED H:E9 :>>F?@=@8:42= 5:D62D6D]Qk^Am
kAmQx 2> 9@?@C65 E@ ;@:? w2C3@FC q:@|65 2D $4:6?E:7:4 p5G:D@C 7@C x>>F?@=@8J 2E DF49 2? 6I4:E:?8 DE286 @7 E96 r@>A2?JVD 8C@HE9[Q D2:5 sC] {=@J5 z=:4<DE6:?] Qw2C3@FC q:@|65 92D 3F:=E 2 5:776C6?E:2E65 A@CE7@=:@ 6>A=@J:?8 E96:C AC@AC:6E2CJ 2?E:3@5J 5:D4@G6CJ A=2E7@C>D H:E9 E96 A@E6?E:2= E@ 255C6DD D:8?:7:42?E F?>6E ?665D :? :>>F?@=@8:42= 5:D62D6D] x =@@< 7@CH2C5 E@ H@C<:?8 4=@D6=J H:E9 E96 E62> E@ 96=A 25G2?46 :??@G2E:G6 :>>F?@=@8J AC@8C2>D[ :56?E:7J AC@>:D:?8 ?6H E96C2A6FE:4 @AA@CEF?:E:6D[ 2?5 F=E:>2E6=J 3C:?8 >62?:?87F= EC62E>6?E @AE:@?D E@ A2E:6?ED]Qk^Am
kAmkDEC@?8mp3@FE w2C3@FC q:@|65k^DEC@?8mk^Am
kAmw2C3@FC q:@|65 Wwzt)i _a`caX :D 2 8=@32= 3:@A92C>246FE:42= 4@>A2?J 4@>>:EE65 E@ E96 5:D4@G6CJ 2?5 56G6=@A>6?E @7 ?@G6= 2?E:3@5J E96C2A6FE:4D :? :>>F?@=@8J[ @?4@=@8J 2?5 @E96C 2C62D] %96 r@>A2?J :D 3F:=5:?8 2 C@3FDE A@CE7@=:@ 2?5 5:776C6?E:2E65 A:A6=:?6 E9C@F89 :?E6C?2= #U2>Ajs 42A23:=:EJ[ DEC2E68:4 8=@32= 4@==23@C2E:@?D :? 4@\5:D4@G6CJ 2?5 4@\56G6=@A>6?E[ 2?5 D6=64E:G6 24BF:D:E:@?D]k^Am
kAm~FC AC@AC:6E2CJ 2?E:3@5J E649?@=@8J A=2E7@C>[ w2C3@FC |:46kDFAm®k^DFAm[ 86?6C2E6D 7F==J 9F>2? >@?@4=@?2= 2?E:3@5:6D :? 3@E9 E96 4@?G6?E:@?2= EH@ 962GJ 2?5 EH@ =:89E 492:? Wwa{aX 7@C>2E 2?5 E96 962GJ 492:?\@?=J Wwrp3X 7@C>2E] qF:=5:?8 FA@? wrp3 2?E:3@5:6D[ E96 wrp3\32D65 :>>F?6 46== 6?8286CD WwqxrtkDFAm®k^DFAmX 3:DA64:7:4 2?E:3@5J E649?@=@8J 6?23=6D EF>@C\<:==:?8 67764ED E92E EC25:E:@?2= 4@>3:?2E:@? E96C2A:6D 42??@E 249:6G6] %96 wrp3\32D65 p?E:3@5J !=FD E649?@=@8J Wwrp3 !{&$™X AC@G:56D 4@>AC696?D:G6 >@52=:EJ D@=FE:@?D 7@C E96 56G6=@A>6?E @7 :??@G2E:G6 >F=E:\DA64:7:4 >65:4:?6D :? 5:776C6?E 5:D62D6 2C62D] p55:E:@?2==J[ 3F:=5:?8 FA@? E96 w2C3@FC |:46kDFAm®k^DFAm A=2E7@C>[ w2C3@FC q:@|65 =2F?4965 :ED 7:CDE 7F==J 9F>2? v6?6C2E:G6 px wrp3 |@56= A@H6C65 3J :ED wF\>pECxI™ px A=2E7@C>[ 2446=6C2E:?8 E96 56G6=@A>6?E @7 :??@G2E:G6 E96C2A:6D]k^Am
kAmqJ :?E68C2E:?8 w2C3@FC |:46kDFAm®k^DFAm[ wqxrtkDFAm®k^DFAm[ wrp3 !{&$kDA2?m™k^DA2?m[ 2 D:?8=6 q\46== 4=@?:?8 A=2E7@C> 2?5 px E649?@=@8:6D[ w2C3@FC q:@|65 92D 3F:=E 2 9:89=J 677:4:6?E 2?5 5:DE:?4E:G6 2?E:3@5J 5:D4@G6CJ 6?8:?6 7@C 56G6=@A:?8 ?6IE\86?6C2E:@? E96C2A6FE:4 2?E:3@5:6D] u@C >@C6 :?7@C>2E:@?[ A=62D6 G:D:E k2 9C67lQ9EEADi^^HHH]92C3@FC3:@>65]4@>^Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmHHH]92C3@FC3:@>65]4@>k^2m]k^Am
kA :5lQ!&#{Qmk:>8 E:E=6lQr:D:@?Q H:5E9lQ`aQ 96:89ElQ`aQ 2=ElQr:D:@?Q DC4lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^:>8^72G:4@?]A?8nD?lr}hbg`gU2>AjD5la_ae\_e\agQ ^m ':6H @C:8:?2= 4@?E6?E E@ 5@H?=@25 >F=E:>65:2ik2 :5lQ!#}&#{Q C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^92C3@FC\3:@>65\2AA@:?ED\5C\==@J5\<=:4<DE6:?\2D\D4:6?E:7:4\25G:D@C\7@C\:>>F?@=@8J\b_ag`afha]9E>=Q E2C86ElQ03=2?<Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^92C3@FC\3:@>65\2AA@:?ED\5C\==@J5\<=:4<DE6:?\2D\D4:6?E:7:4\25G:D@C\7@C\:>>F?@=@8J\b_ag`afha]9E>=k^2mk^Am
kAm$~&#rt w2C3@FC q:@|65k^Am
kAmk:>8 2=ElQQ DC4lQ9EEADi^^CE]AC?6HDH:C6]4@>^CE]8:7n}6HDxE6>x5lr}hbg`gU2>Aj%C2?D>:DD:@?0x5la_ae_eaga`af!#0}t($0&$!#00000r}hbg`gU2>Ajs2E6x5la_ae_eagQ DEJ=6lQ3@C56Ci_AIj H:5E9i`AIj 96:89Ei`AIjQ ^mk^Am
